Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Entasis Therapeutics (United States) | Researchclopedia

Back to institutions

Entasis Therapeutics (United States)

Walthamcompany

105

Works

16,109

Citations

65

h-index

Top Research Topics

Antibiotic Resistance in Bacteria Antibiotics Pharmacokinetics and Efficacy Antibiotic Use and Resistance

Top Researchers

Richard H. Duerr

224 works36,392 citationsh-index: 68

Recent Research

P-443. Population Pharmacokinetics (PPK) Analysis of Eravacycline (ERV) to Support Dose Selection for a Trial in Pediatric Patients Aged 8 to Less Than 18 Years with Complicated Intra-Abdominal Infection (cIAI)

Claudia Jomphe,Nathalie Gosselin,et al.

20260 citations

Reproductive tract infections research

Pneumonia and Respiratory Infections

Cancer therapeutics and mechanisms

Pharmaceutical and Antibiotic Environmental Impacts

Bacterial Infections and Vaccines

Vibrio bacteria research studies

Pharmaceutical studies and practices

Bacterial Genetics and Biotechnology

Berberine and alkaloids research

Scott B. Snapper Université Mohammed VI Polytechnique

536 works32,705 citationsh-index: 85

Joshua R. Korzenik Brigham and Women's Hospital

321 works17,528 citationsh-index: 56

Humphrey Gardner

166 works11,787 citationsh-index: 55

Themistocles Dassopoulos

133 works11,260 citationsh-index: 31

Meenakshi Bewtra

145 works11,092 citationsh-index: 34

P-444. Population Pharmacokinetics (PPK) Analysis of Sulbactam-Durlobactam (SUD) to Support Dose Selection for Evaluation in a Clinical Trial in Pediatric Patients with Acinetobacter Baumannii-Calcoaceticus Complex (ABC) Infections

Kajal Larson,John O’Donnell,et al.

20260 citations

Letter to the editor regarding “Alternative drugs for the treatment of gonococcal infections: old and new” <i>Expert Review of Anti-infective Therapy</i> . 2024. 22(9):753–759

Alison Luckey,David Altarac,et al.

20250 citations

P-1251. Pharmacometric Analyses to Support Dose Selection of Zoliflodacin, a First-in-Class Oral Antibiotic Being Developed for the Treatment of Uncomplicated Gonorrhea

Sujata M. Bhavnani,Anthony P Cammarata,et al.

20251 citations

Population pharmacokinetic analyses for sulbactam–durlobactam using Phase 1, 2, and 3 data

Anthony P Cammarata,M. Courtney Safir,et al.

20248 citations

In vitro antibacterial activity of sulbactam-durlobactam in combination with other antimicrobial agents against Acinetobacter baumannii-calcoaceticus complex

Sarah M. McLeod,Nicole Carter,et al.

20246 citations